Aventis, Sandoz Drop Swords In Taxotere Patent Suit
Aventis Pharma SA and Sanofi-Aventis U.S. LLC decided Friday to stop fighting a judgment in favor of Sandoz Inc. in its patent suit over Sandoz's generic version of cancer treatment Taxotere....To view the full article, register now.
Already a subscriber? Click here to view full article